Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020
Authors' conclusion
This study provides prevalence estimates of treated hyper- and hypo-thyroidism at the national and departmental levels in France and improves epidemiological knowledge of both conditions. It also supports using healthcare claims data for their epidemiological surveillance.
Study context
- Population
- Population residing in France (over 67 million inhabitants, metropolitan and overseas departments), French national healthcare data system, 2020over 67 million inhabitants
- Participants
- 112,992 vs 2,986,333
- Exposure
- Hyperthyroidism vs Hypothyroidism
- Hyperthyroidismn = 112,992
- Hypothyroidismn = 2,986,333
- Outcome
- Prevalence of treated hyper- and hypothyroidism
- Follow-up
- 2020
Methodological detailsnationwide, healthcare claims data
- Nationwide
- Healthcare claims data
Main finding
As reported in the abstract
Hyperthyroidism
0.17 per 100 inhabitants
112,992 of 112,992
Hypothyroidism
4.45 per 100 inhabitants
2,986,333 of 2,986,333
Observational data: associations, not effects.
Further findings
Differences by sex, age group, department and deprivation level · 2020
- Marked differences by sex, age group and department for both conditions, and by deprivation level of place of residence for hyperthyroidism only
Hypothyroidism following previous therapy for thyroid cancer or hyperthyroidism · 2020
- Proportion of hypothyroidism following previous therapy for thyroid cancer or hyperthyroidism
- less than 10%
Adequate monitoring of hypothyroid subjects (TSH checked in the past year) · 2020
- Adequate monitoring (TSH checked in past year) in hypothyroid subjects
- 73.7%
- Large variations across departments
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →